1-6 of 6
Kohei Shitara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract C113: Multiple modalities of single cell analyses to evaluate the tumor microenvironment in clinical specimens

Yukie Kashima, Shota Fukuoka, Yosuke Togashi, Takahiro Kamada, Ayako Suzuki, Yoshiaki Nakamura, Kohei Shitara, Akihiro Ohashi, Taku Yoshida, Naofumi Taoka, Tatsuya Kawase, Teiji Wada, Kocihiro Inaki, Masataka Chihara, Yutaka Suzuki, Katsuya Tsuchihara, Susumu S Kobayashi, Hiroyoshi Nishikawa, Toshihiko Doi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C113.
https://doi.org/10.1158/1535-7163.TARG-19-C113
Published: 01 December 2019
View article titled, Abstract C113: Multiple modalities of single cell analyses to evaluate the tumor microenvironment in clinical specimens
Journal Articles

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

Akihiko Shimomura, Noboru Yamamoto, Shunsuke Kondo, Yutaka Fujiwara, Shigenobu Suzuki, Noriko Yanagitani, Atsushi Horiike, Satoru Kitazono, Fumiyoshi Ohyanagi, Toshihiko Doi, Yasutoshi Kuboki, Akihito Kawazoe, Kohei Shitara, Izumi Ohno, Udai Banerji, Raghav Sundar, Shuichi Ohkubo, Elizabeth M. Calleja, Makoto Nishio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 531–540.
https://doi.org/10.1158/1535-7163.MCT-18-0831
Published: 01 March 2019
View article titled, First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors
Open the PDF for First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors in another window
Journal Articles

Abstract A204: INCB024360 (Epacadostat) monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: primary results from first-in-Japanese phase I study (KEYNOTE-434)

Yutaka Fujiwara, Kohei Shitara, Toshio Shimizu, Kan Yonemori, Nobuaki Matsubara, Izumi Ohno, Takahiro Kogawa, Yoichi Naito, Lance Leopold, Kahori Sasahara, Naoyoshi Yatsuzuka, Tomoko Takami, Takashi Shimamoto, Noboru Yamamoto, Toshihiko Doi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (1_Supplement): A204.
https://doi.org/10.1158/1535-7163.TARG-17-A204
Published: 01 January 2018
View article titled, Abstract A204: INCB024360 (Epacadostat) monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: primary results from first-in-Japanese phase I study (KEYNOTE-434)
Journal Articles

Abstract A167: A phase I study of MET TKI SAR125844 in Asian patients (pts) with advanced solid tumors

Kohei Shitara, Do-Youn Oh, Tomoya Yokota, Tae Won Kim, Toshihiko Doi, Satoshi Hamauchi, Jin-Hee Ahn, Corinne Gomez, Marzia Harnois, Yung Jue Bang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A167.
https://doi.org/10.1158/1535-7163.TARG-15-A167
Published: 01 December 2015
View article titled, Abstract A167: A phase I study of MET TKI SAR125844 in Asian patients (pts) with advanced solid tumors
Journal Articles

Abstract B29: Feasibility of amplicon sequencing using a pan-cancer gene panel with pre-treatment biopsy samples of (Japanese) patients with advanced solid tumors: Analyses of Biopsy Samples for Cancer Genomics (ABC) study.

Hideaki Takahashi, Kohei Shitara, Takeshi Kuwata, Yoichi Naito, Shingo Matsumoto, Wataru Okamoto, Seiji Niho, Hideaki Bando, Yasutoshi Kuboki, Yoko Yamada, Izumi Miki, Takeharu Yamanaka, Atsushi Watanabe, Motohiro Kojima, Genichiro Ishii, Satoshi Fujii, Shigeki Umemura, Masafumi Ikeda, Takashi Kohno, Akihiro Sato, Atsushi Ohtsu, Hiroyasu Esumi, Atsushi Ochiai, Takayuki Yoshino, Katsuya Tsuchihara
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B29.
https://doi.org/10.1158/1535-7163.TARG-13-B29
Published: 01 November 2013
View article titled, Abstract B29: Feasibility of amplicon sequencing using a pan-cancer gene panel with pre-treatment biopsy samples of (Japanese) patients with advanced solid tumors: Analyses of Biopsy Samples for Cancer Genomics (ABC) study.
Journal Articles

Abstract B54: Phase I study of ombrabulin in combination with cisplatin (CDDP) administered every 3 weeks to Japanese patients with advanced solid tumors.

Takashi Ura, Shunji Takahashi, Tomoya Yokota, Kohei Shitara, Kei Muro, Kenji Nakano, Keisho Chin, Masahiro Yokoyama, Kiyohiko Hatake, Takekazu Aoyama
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B54.
https://doi.org/10.1158/1535-7163.TARG-11-B54
Published: 12 November 2011
View article titled, Abstract B54: Phase I study of ombrabulin in combination with cisplatin (CDDP) administered every 3 weeks to Japanese patients with advanced solid tumors.